HMG-CoA reductase inhibitors and method

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6627636
APP PUB NO 20020094977A1
SERIAL NO

10007407

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of the following structure are HMG CoA reductase inhibitors and thus are active in inhibiting cholesterol biosynthesis, modulating blood serum lipids such as lowering LDL cholesterol and/or increasing HDl cholesterol, and treating hyperlipidemia, hypercholesterolemia, hypertriglyceridemia and atherosclerosis ##STR1## and pharmaceutically acceptable salts thereof, wherein X is O, S, SO, SO.sub.2 or NR.sub.7 ; Z is ##STR2## n is 0 or 1; R.sub.1 and R.sub.2 are the same or different and are independently selected from alkyl, arylalkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, heteroaryl or cycloheteroalkyl; and R.sub.3 to R.sub.10 are as defined herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BRISTOL-MYERS SQUIBB COMPANYROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Robl, Jeffrey A Newtown, PA 80 1827

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation